GI tract tumours

Gene: MBD4

Green List (high evidence)

MBD4 (methyl-CpG binding domain 4, DNA glycosylase)
EnsemblGeneIds (GRCh38): ENSG00000129071
EnsemblGeneIds (GRCh37): ENSG00000129071
OMIM: 603574, Gene2Phenotype
MBD4 is in 4 panels

3 reviews

Terri McVeigh (Royal Marsden NHS Foundation Trust)

Green List (high evidence)

Discussed at Cancer/Scientific Leads/UKCGG council meeting re Test Directory updates 2025/2026 (30/01/2025) - consensus was that evidence is sufficient to warrant addition of this gene to R211 panel as well as R347.
Created: 24 Apr 2025, 8:53 a.m. | Last Modified: 24 Apr 2025, 8:53 a.m.
Panel Version: 1.22

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
MBD4-Associated Neoplasia Syndrome: Colonic polyposis; colon cancer; uveal melanoma; acute myeloid leukaemia; schwannoma

Publications

Arina Puzriakova (Genomics England Curator)

Comment on list classification: This gene was reviewed by the cancer expert group and the evidence was determined as sufficient for inclusion on this panel. Therefore, upgrading from Amber to Green.
Created: 13 Jun 2025, 11:07 a.m. | Last Modified: 13 Jun 2025, 11:07 a.m.
Panel Version: 1.25
- Palles et al. 2022 (PMID: 35460607) reported on 5 individuals from 4 families with biallelic MBD4 variants who had a personal and/or family history of adenomatous colorectal polyposis (5/5), AML (1/5 personal), and uveal melanoma (2/5 personal). Consistent with previous studies, MBD4-deficient colorectal adenomas showed a significantly increased mutational burden compared to sporadic colorectal tumours, which were mostly attributable to an excess of CpG>TpG transitions.

- Sanders et al. 2018 (PMID: 30049810) demonstrated in 3 individuals with AML (including 2 sibs) and LoF variants in MBD4, that MBD4-deficient cancers exhibit a unique mutational signature with high burden of CpG>TpG transitions. Note that PMID: 32239153 refer to the same individuals.

The MBD4-related hypermutator phenotype has also been detected in Mbd4 mutant mice (PMID:12417741) and other human cancers such as uveal melanoma and colorectal tumours (PMID: 29760383; 32239153; 31322271).
Created: 5 Jul 2022, 3:13 p.m. | Last Modified: 5 Jul 2022, 3:13 p.m.
Panel Version: 1.19

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma

Publications

Claire Palles (University of Birmingham)

Green List (high evidence)

Bi-allelic loss of function mutation carriers at high risk of early onset AML, colorectal polyposis an uveal melanoma. Heterozygous monoallelic carriers at no significantly increased risk in data so far.
Sources: Literature
Created: 30 Jun 2022, 10:47 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
polyposis; CRC; AML; MDS; UVM

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
Phenotypes
  • Tumor predisposition syndrome 2, OMIM:619975
  • Multi-organ tumour predisposition syndrome
  • Adenomatous colorectal polyposis
  • Colorectal cancer
  • Acute myeloid leukemia
  • Uveal melanoma
OMIM
603574
Clinvar variants
Variants in MBD4
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

13 Jun 2025, Gel status: 3

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: mbd4 has been classified as Green List (High Evidence).

13 Jun 2025, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: mbd4 has been classified as Amber List (Moderate Evidence).

13 Jun 2025, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: MBD4 were set to 12417741; 30049810; 32239153; 35460607

13 Jun 2025, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: MBD4 were changed from Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma to Tumor predisposition syndrome 2, OMIM:619975; Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma

5 Jul 2022, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: mbd4 has been classified as Amber List (Moderate Evidence).

5 Jul 2022, Gel status: 0

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: MBD4 were changed from polyposis; CRC; AML; MDS; UVM to Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma

5 Jul 2022, Gel status: 0

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: MBD4 were set to 35460607

30 Jun 2022, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance

Claire Palles (University of Birmingham)

gene: MBD4 was added gene: MBD4 was added to GI tract tumours. Sources: Literature Mode of inheritance for gene: MBD4 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MBD4 were set to 35460607 Phenotypes for gene: MBD4 were set to polyposis; CRC; AML; MDS; UVM Penetrance for gene: MBD4 were set to Complete Review for gene: MBD4 was set to GREEN